|
Viruses of Concern
Since the SARS-CoV-2 outbreak in late 2019, the global impact of infectious diseases has drawn renewed attention. Throughout history—smallpox, plague, Spanish flu—such diseases have shaped human society. Today, threats like influenza, rabies, RSV, and HPV continue to challenge public health. As a result, accelerating the development of safe and effective vaccines and therapeutics remains a top priority across the scientific and biopharma community.
ACROBiosystems has accumulated mature technology and experience in viruses and vaccines. Since the COVID-19 outbreak, we continued to develop core reagents for other infectious virus research, vaccine, and therapeutic drug development based on its high-quality platform. We will continue to monitor the development of infectious diseases worldwide, aiming to provide core reagents for accelerating the development and clinical trials of vaccines and therapeutic drugs.
|
